These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
41 related articles for article (PubMed ID: 3037144)
21. [Treatment of non-small cell cancer of the lung with a combination of cisplatin-VP-16 and mitomycin C]. Arraztoa J; Orlandi L; Rodríguez R; Vogel C; Ramírez G Rev Med Chil; 1987 Jan; 115(1):31-6. PubMed ID: 3039639 [No Abstract] [Full Text] [Related]
22. Circadian variability of pharmacokinetics of cisplatin in patients with non-small-cell lung carcinoma: analysis with the NONMEM program. Chen R; Li J; Hu WW; Wang ML; Zou SL; Miao LY Cancer Chemother Pharmacol; 2013 Nov; 72(5):1111-23. PubMed ID: 24061864 [TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetics of cisplatin in patients with small cell cancer of the lung]. Kulik GI; Solianik GI; Lipovoĭ AS; Bagirian MA; Biriuk LI Vopr Onkol; 1991; 37(5):568-71. PubMed ID: 1662838 [TBL] [Abstract][Full Text] [Related]
24. Advances in non-small-cell lung cancer treatment. Strategies include repeat biopsies and counting circulating cells. Duke Med Health News; 2011 Jun; 17(6):7. PubMed ID: 21710702 [No Abstract] [Full Text] [Related]
25. Treatment of lung cancer with bronchial artery infusion of cisplatin and intravenous sodium thiosulfate rescue. Uchiyama N; Kobayashi H; Nakajo M; Shinohara S Acta Oncol; 1988; 27(1):57-61. PubMed ID: 2835068 [TBL] [Abstract][Full Text] [Related]
26. Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based chemotherapy. Smith DH; Goldwasser E; Vokes EE Cancer; 1991 Sep; 68(5):1101-5. PubMed ID: 1655216 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of intravenous ATP in cancer patients. Agteresch HJ; Dagnelie PC; Rietveld T; van den Berg JW; Danser AH; Wilson JH Eur J Clin Pharmacol; 2000 Apr; 56(1):49-55. PubMed ID: 10853877 [TBL] [Abstract][Full Text] [Related]
29. Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma. Fossella FV; Winn RJ; Holoye PY; Raber MN; Holden L; Belt R; Allen H; Hallinan B; Harper K Invest New Drugs; 1991 Nov; 9(4):375-6. PubMed ID: 1666631 [No Abstract] [Full Text] [Related]
30. Cisplatin binding to plasma proteins and hemoglobin in cancer patients. Mustonen R; Hemminki K; Hietanen P; Leppälä S; Takala M Arch Toxicol Suppl; 1989; 13():262-4. PubMed ID: 2774942 [No Abstract] [Full Text] [Related]
31. [Therapeutic efficacy and pharmacokinetics of cisplatin in patients with non-small cell lung cancer]. Fukuoka M; Kitajima K; Takada M; Negoro M; Matsui S; Kusunoki K; Ryu Y; Sakai S; Takifuji N; KimuraT Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jan; 25(1):44-9. PubMed ID: 3037144 [No Abstract] [Full Text] [Related]
32. [Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer]. Seike M; Andoh M; Hasegawa K; Sakonji M; Tsuboi E Gan To Kagaku Ryoho; 1998 Aug; 25(10):1539-42. PubMed ID: 9725046 [TBL] [Abstract][Full Text] [Related]
33. Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro. Oshita F; Yamamoto N; Fukuda M; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N Cancer Res; 1995 Jun; 55(11):2334-7. PubMed ID: 7757984 [TBL] [Abstract][Full Text] [Related]
34. [Concurrent daily low-dose cisplatin combined with chest irradiation in advanced non-small cell lung cancer]. Fujii S; Hamamoto Y; Sugai Y Gan To Kagaku Ryoho; 1993 Aug; 20(10):1397-9. PubMed ID: 8394063 [No Abstract] [Full Text] [Related]
35. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer. von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121 [TBL] [Abstract][Full Text] [Related]